During the past decade, Hogar Clínica San Juan de Dios conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hogar Clínica San Juan de Dios" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hogar Clínica San Juan de Dios" are "Systemic Lupus Erythematosus" (2 trials), "Lupus Erythematosus, Systemic" (1 trials), "Lupus Nephritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Hogar Clínica San Juan de Dios" in a lesser frequency.

Most popular intervention types in "Hogar Clínica San Juan de Dios" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Methylprednisolone" (2 trials), "Obinutuzumab" (2 trials), "Acetaminophen" (1 trials) and "Acetaminophen/Paracetamol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hogar Clínica San Juan de Dios" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hogar Clínica San Juan de Dios". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hogar Clínica San Juan de Dios, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hogar Clínica San Juan de Dios, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".